RxDoctor Payments Data

Scott Teeter

Internal Medicine · Topeka, KSNPI 1245242346

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Astellas Pharma US Inc at 39.6% of the total.

$185in general payments, 2019–2025

Across 18 payments — averaging $10.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$73
  • Amgen$24
  • Sanofi-aventis U.S. LLC$23
  • Merck$15
  • Novo Nordisk$14
  • AbbVie$13
  • plus $24 from 2 others
$1,226,283in research payments, 2019–2025

Across 106 payments — averaging $11,569 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$781K
  • Merck$445K

What the payments were for

  • Food & beverage$185100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$185 in reported general payments places this provider in the 55th percentile of 705 internal medicine providers in Kansas.

See all internal medicine providers in Kansas

Other internal medicine in Topeka

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →